Physician

Rabeea Aboufakher, MD

According to 2025 Medicare claims, Rabeea Aboufakher, MD (NPI: 1881896223) practices interventional cardiology in the Grand Forks, ND-MN market, with the plurality of this provider's patient population coming from Grand Forks, ND. This provider's primary affiliated billing organization is ALTRU HEALTH SYSTEM (NPI: 1043309552; TIN: 450310462) and primary practice location at 58201-4036. Aboufakher is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), CVS ACO (ACO ID: A5407), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Aboufakher's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 883 traditional Medicare patients, billed 1,624 HCPCS/CPT codes, and received $89,753 in Medicare payments. The top billing code was 93458 (Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist). Part D data shows 414 prescription claims across 107 beneficiaries totaling $36,552 in drug costs, led by Xarelto (Rivaroxaban). 2019 DME data shows 12 claims. Open Payments data shows 2 records totaling $184. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $207,206 to $89,753. Similarly, Part D prescription costs have fallen sharply in recent years, from $151,123 to $36,552. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,105 to $284.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,495	5,313	$207,206
2016	2,193	5,221	$216,147
2017	2,450	5,586	$269,823
2018	2,582	6,189	$249,386
2019	1,891	3,615	$163,859
2020	390	590	$21,990
2021	636	1,063	$54,057
2022	295	550	$36,966
2023	667	1,092	$50,936
2024	883	1,624	$89,753

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	516	4,215	$151,123
2016	494	3,457	$172,275
2017	538	2,701	$173,880
2018	648	4,195	$298,385
2019	429	2,439	$184,094
2020	90	219	$16,617
2021	15	56	$834
2022	19	63	$1,467
2023	22	92	$5,673
2024	107	414	$36,552

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$334
2019	N/R	12	$284
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93458	Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist	88	88	$161
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	234	234	$52
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	127	130	$9
93793	Anticoagulant management of patient taking warfarin	166	218	$8
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	215	233	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	16	540	$9,205
Clopidogrel	Clopidogrel Bisulfate	128	5,024	$835
Atorvastatin Calcium	Atorvastatin Calcium	48	2,013	$372
Metoprolol Succinate	Metoprolol Succinate	23	1,245	$285
Losartan Potassium	Losartan Potassium	23	1,410	$228

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$184	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rabeea Aboufakher, MD?

Tedicare shows public-source Medicare data for Rabeea Aboufakher, MD (NPI 1881896223), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rabeea Aboufakher, MD have ACO affiliation data?

Rabeea Aboufakher, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), CVS ACO (MSSP, ACO ID A5407), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Rabeea Aboufakher, MD?

Rabeea Aboufakher, MD is linked to ALTRU HEALTH SYSTEM (billing NPI 1043309552) in the available physician profile data.

Does Rabeea Aboufakher, MD have Open Payments data?

Rabeea Aboufakher, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.